学习经历    

2001.9－2005.6  中国地质大学外国语学院 英语专业 学士

2003.2－2005.6  武汉大学生命科学学院 生物科学专业 学士

2005.9－2010.6  武汉大学生命科学学院 细胞生物学 博士 导师：舒红兵院士                     

工作经历  

2010.7－2013.2  The University of Texas MD Anderson Cancer Center 博士后 导师：董晨 教授  

2013.3－      武汉大学生命科学学院 病毒学国家重点实验室

           武汉大学医学研究院 教授、博导      

获奖与荣誉  

2015  武汉大学十大杰出青年

2012  “全国百篇优秀博士论文”获得者，中国

2012  美国免疫学家学会“Abstract Award”，美国

2011  Odyssey Fellowship, MD Anderson Cancer Center

2010  应邀参加第60届“诺贝尔获奖者大会”，德国

2009  吴瑞奖，吴瑞基金会，美国

主要社会兼职  

中国细胞生物学会青年委员会委员

中国免疫学会青年委员会委员

Sci Rep, JBC, ActaBiochimBiophys Sin, Immunologic Research等杂志应邀审稿人

研究兴趣

  本实验室主要从事抗病毒天然免疫信号转导、炎性细胞因子介导的炎症反应与肿瘤发生的分子机理的研究。我们主要以表达克隆、酵母双杂交以及蛋白质组学等多种手段，筛选参与调控抗病毒天然免疫以及炎症反应过程的蛋白，并通过基因敲除、转基因小鼠以及动物疾病模型研究这些蛋白在调控病毒感染、自身免疫性疾病以及肿瘤发生等过程中的功能与机制。  

主持课题项目        

（1）抗病毒天然免疫机制的研究，国家重大基础研究计划子项目，2014-2018

（2）去泛素化酶USP25调节Toll样受体介导信号转导的机制，国家自然科学基金面上项目，2014-2017

（3）炎症细胞因子调控非小细胞肺癌发生的分子机制研究，教育部优秀博士论文获得者基金，2015-2017

（4）病毒免疫学，自然科学基金优秀青年科学基金，2017-2019

（5）USP18调控病毒感染诱导Ⅰ型干扰素表达的机制研究，国家自然科学基金面上项目，2017-2020

（6）cGAS与STING的去泛素化修饰及其调控抗病毒免疫与自身免疫的功能与机制研究，国家自然科学基金委重点项目，2020-2024

（7）国际重要新发病毒的致病机制，科技部重点研发计划，2018-2022

代表性论文

1. Li SZ*, Shu QP, Song Y, Zhang HH, Liu Y, Jin BX, Liuyu TZ, Li C, Huang XC, Du RL, Song W*, Zhong B*, Zhang XD*. Phosphorylation of MAVS/VISA by Nemo-like kinase (NLK) for degradation regulates the antiviral innate immune response. Nat Commun, 2019, 10(1): 3233.

2. Ye L#, Zhang Q#, Liuyu T, Xu Z, Zhang MX, Luo MH, Zeng WB, Zhu Q, Lin D*, Zhong B*. USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA. Plos Pathog, 2019, 15(4): e1007680.

3. Zhang MX, Cai Z, Zhang M, Wang XM, Wang Y, Zhao F, Zhou J, Luo MH, Zhu Q, Xu Z, Zeng WB*, Zhong B*, Lin D*. USP20 promotes cellular antiviral responses via deconjugating K48-linked ubiquitination of MITA. J Immunol, 2019, 202(8):2397-2406.

4. Liuyu T, Yu K, Ye L, Zhang Z, Zhang M, Ren Y, Cai Z, Zhu Q, Lin D, Zhong B*, Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS. Cell Res, 2019, 29(1):67-79.

5. Zhao Y, Wang XM, Wang Q, Deng Y, Li K, Zhang M, Zhang Q, Zhou J, Wang HY, Bai P, Ren Y, Zhang N, Li W, Cheng Y, Xiao W, Du HN, Cheng X, Yin L, Fu X, Lin D, Zhou Q, Zhong B*, USP2a supports metastasis by tuning TGF-b signaling. Cell Rep, 2018, 22(9):2442-2454.

6. Li K, Zhong B*, Regulation of cellular antiviral signaling by modifications of ubiquitin and ubiquitin-like molecules. Immune Network. 2018, 18(1):e4. (Invited review)

7. Lu B#, Ren Y#, Sun X#, Han C, Wang H, Chen Y, Peng Q, Cheng Y, Cheng X, Zhu Q, Li W, Li HL,  Du HN, Zhong B*, Huang Z*. Induction of INKIT by viral infection negatively regulates antiviral responses through inhibiting phosphorylation of p65 and IRF3. Cell Host Microbe, 2017, 22(1):86-98.e4.  (Cover story)

8. Sun H#, Zhang Q#, Jing YY, Zhang M, Wang HY, Cai Z, Liuyu T, Zhang ZD, Xiong TC, Wu Y, Zhu QY, Yao J, Shu HB, Lin D, Zhong B*. USP13 negatively regulates antiviral responses by deubiquitinating STING. Nat Commun. 2017, May 23; 8:15534. 10.1038/NCOMMS15534.

9. Zhang M#, Zhang MX#, Zhang Q, Zhu GF, Yuan L, Zhang DE, Zhu QY, Yao J, Shu HB, Zhong B*. USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA. Cell Res. 2016, 26(12): 1302-1319.

10. Ren Y, Zhao Y, Lin D, Xu X, Zhu Q, Yao J, Shu HB, Zhong B*. The type I interferon-IRF7 axis mediates virus-triggered upregulation of Usp25 gene. J Biol Chem. 2016, 291(25): 13206-13215.

11. Lin D, Zhang M, Zhang MX, Ren YJ, Zhao Q, Jin J, Pan Z, Wu M, Shu HB, Dong C, Zhong B*. Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6. Proc Natl Acad Sci U S A. 2015 112(36):11324-329.

12. Lin D, Zhong B*. Regulation of cellular innate antiviral signaling by ubiquitin modification. Acta Biochim Biophys Sin. 2015 47(3):149-155. (Invited Review)

13. Zhong B, Liu XK, Wang XH, Liu XD, Li HX, Darnay BR, Lin X, Sun SC and Dong C. Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune response through deubiquitination of TRAF3. (2013). Sci Signal. 6, ra35.

14. Liu XK#, Li HX#, Zhong B#, Blonska M, Gorjestani S, Yan M, Tian Q, Zhang DE, Lin X and Dong C. USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex. (2013). J Exp Med. 210, 1575-90. (#Co-first authors)

15. Zhong B, Liu XK, Wang XH, Chang SH, Liu XD, Wang AB, Reynolds JM, and Dong C. Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. (2012). Nat Immunol. 13, 1110-17.

16. Zhong B, Zhang Y, Tan B, Liu TT, Wang YY and Shu HB. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. (2010). J Immunol. 184, 6249-6255.

17. Zhong B, Wang YY and Shu HB. Regulation of virus-triggered type I interferon signaling by cellular and viral proteins. (2010). Frontier in Biology 5, 12-31.

18. Zhong B, Zhang L, Lei CQ, Li Y., Mao AP, Yang Y, Wang YY, Zhang XL and Shu HB. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. (2009). Immunity 30, 397-407.

19. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao FC, Lei CQ, He X, Zhang L, Tien, P and Shu HB. The adapter protein MITA links virus-sensing receptors to IRF3 transcription factor activation. (2008). Immunity 29, 538–550.

20. Zhong B, Tien P and Shu HB. Innate immune responses: crosstalk of signaling and regulation of gene transcription. (2006). Virology 352, 14-21.